Ibrutinib for rituximab-refractory Waldenström macro-globulinemia

Oncotarget. 2017 Dec 18;9(16):12536-12537. doi: 10.18632/oncotarget.23400. eCollection 2018 Feb 27.

Authors

Maria Gavriatopoulou¹, Efstathios Kastritis¹, Meletios Athanasios Dimopoulos¹

Affiliation

¹ Department of Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

No abstract available

Keywords: Waldenström Macroglobulinemia; chemoimmunotherapy; ibrutinib; rituximab-refractory; treatment strategies.

Publication types

Editorial